Aquaporin 4 and neuromyelitis optica

The Lancet Neurology

Volumn 11, Issue 6, 2012, Pages 535-544

  Papadopoulos, Marios C ^a   Verkman, A S ^b  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 4; AQUAPORUMAB; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; ECULIZUMAB; IMMUNOGLOBULIN G; METHYLPREDNISOLONE; MITOXANTRONE; MONOCLONAL ANTIBODY; MYCOPHENOLIC ACID; MYELIN; RITUXIMAB; SIVELESTAT; UNCLASSIFIED DRUG;

ASTROCYTE; CELLULAR DISTRIBUTION; CORTICOSTEROID THERAPY; CYTOTOXICITY; GENETIC VARIABILITY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAINTENANCE THERAPY; MYELOOPTIC NEUROPATHY; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PLASMAPHERESIS; PREVALENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; T LYMPHOCYTE; CELL DEATH; COMPLEMENT ACTIVATION; INTERNALIZATION; PROTEIN LOCALIZATION;

AQUAPORIN 4; HUMANS; IMMUNOGLOBULIN G; INFLAMMATION MEDIATORS; NEUROMYELITIS OPTICA;

EID: 84861138201     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(12)70133-3     Document Type: Review

References (113)

1. Jarius S, Wildemann B 'Noteomielite' accompanied by acute amaurosis (1844): an early case of neuromyelitis optica. J Neurol Sci 2012, 313:182-184.
2. Jarius S, Wildemann B The case of the Marquis de Causan (1804): an early account of visual loss associated with spinal cord inflammation. J Neurol Sci 2012, 313:182-184.
3. Jarius S, Wildemann B An early case of neuromyelitis optica: on a forgotten report by Jacob Lockhart Clarke, FRS. Mult Scler 2011, 17:1384-1386.
4. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004, 364:2106-2112.
5. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005, 202:473-477.
6. Collongues N, de Seze J Current and future treatment approaches for neuromyelitis optica. Ther Adv Neurol Disord 2011, 4:111-121.
7. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG Revised diagnostic criteria for neuromyelitis optica. Neurology 2006, 66:1485-1489.
8. Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG The spectrum of neuromyelitis optica. Lancet Neurol 2007, 6:805-815.
9. Mader S, Lutterotti A, Di Pauli F, et al. Patterns of antibody binding to aquaporin-4 isoforms in neuromyelitis optica. PLoS One 2010, 5:e10455.
10. Bourre B, Marignier R, Zephir H, et al. Neuromyelitis optica and pregnancy. Neurology 2012, 78:875-879.
11. Gomori E, Pal J, Abraham H, et al. Fetal development of membrane water channel proteins aquaporin-1 and aquaporin-4 in the human brain. Int J Dev Neurosci 2006, 24:295-305.
12. Jarius S, Paul F, Franciotta D, et al. Neuromyelitis optica spectrum disorders in patients with myasthenia gravis: ten new aquaporin-4 antibody positive cases and a review of the literature. Mult Scler 2011, published online Dec 19. 10.1177/1352458511431728.
13. McKeon A, Lennon VA, Jacob A, et al. Coexistence of myasthenia gravis and serological markers of neurological autoimmunity in neuromyelitis optica. Muscle Nerve 2009, 39:87-90.
14. Matiello M, Kim HJ, Kim W, et al. Familial neuromyelitis optica. Neurology 2010, 75:310-315.
15. Zephir H, Fajardy I, Outteryck O, et al. Is neuromyelitis optica associated with human leukocyte antigen?. Mult Scler 2009, 15:571-579.
16. Wang H, Dai Y, Qiu W, et al. HLA-DPB1 0501 is associated with susceptibility to anti-aquaporin-4 antibodies positive neuromyelitis optica in southern Han Chinese. J Neuroimmunol 2011, 233:181-184.
17. Matiello M, Schaefer-Klein JL, Hebrink DD, Kingsbury DJ, Atkinson EJ, Weinshenker BG Genetic analysis of aquaporin-4 in neuromyelitis optica. Neurology 2011, 77:1149-1155.
18. Crane JM, Rossi A, Gupta T, Bennett JL, Verkman AS Orthogonal array formation by human aquaporin-4: examination of neuromyelitis optica-associated aquaporin-4 polymorphisms. J Neuroimmunol 2011, 236:93-98.
19. Hasegawa H, Ma T, Skach W, Matthay MA, Verkman AS Molecular cloning of a mercurial-insensitive water channel expressed in selected water-transporting tissues. J Biol Chem 1994, 269:5497-5500.
20. Ho JD, Yeh R, Sandstrom A, et al. Crystal structure of human aquaporin 4 at 1·8 A and its mechanism of conductance. Proc Natl Acad Sci USA 2009, 106:7437-7442.
21. Wolburg H, Wolburg-Buchholz K, Fallier-Becker P, Noell S, Mack AF Structure and functions of aquaporin-4-based orthogonal arrays of particles. Int Rev Cell Mol Biol 2011, 287:1-41.
22. Yang B, Brown D, Verkman AS The mercurial insensitive water channel (AQP-4) forms orthogonal arrays in stably transfected Chinese hamster ovary cells. J Biol Chem 1996, 271:4577-4580.
23. Verbavatz JM, Ma T, Gobin R, Verkman AS Absence of orthogonal arrays in kidney, brain and muscle from transgenic knockout mice lacking water channel aquaporin-4. J Cell Sci 1997, 110:2855-2860.
24. Crane JM, Van Hoek AN, Skach WR, Verkman AS Aquaporin-4 dynamics in orthogonal arrays in live cells visualized by quantum dot single particle tracking. Mol Biol Cell 2008, 19:3369-3378.
25. Crane JM, Verkman AS Determinants of aquaporin-4 assembly in orthogonal arrays revealed by live-cell single-molecule fluorescence imaging. J Cell Sci 2009, 122:813-821.
26. Crane JM, Bennett JL, Verkman AS Live cell analysis of aquaporin-4 m1/m23 interactions and regulated orthogonal array assembly in glial cells. J Biol Chem 2009, 284:35850-35860.
27. Crane JM, Lam C, Rossi A, Gupta T, Bennett JL, Verkman AS Binding affinity and specificity of neuromyelitis optica autoantibodies to aquaporin-4 M1/M23 isoforms and orthogonal arrays. J Biol Chem 2011, 286:16516-16524.
28. Phuan PW, Ratelade J, Rossi A, Tradtrantip L, Verkman AS Complement-dependent cytotoxicity in neuromyelitis optica requires aquaporin-4 assembly in orthogonal arrays. J Biol Chem 2012, 287:13829-13839.
29. Furman CS, Gorelick-Feldman DA, Davidson KG, et al. Aquaporin-4 square array assembly: opposing actions of M1 and M23 isoforms. Proc Natl Acad Sci USA 2003, 100:13609-13614.
30. Jin BJ, Rossi A, Verkman AS Model of aquaporin-4 supramolecular assembly in orthogonal arrays based on heterotetrameric association of M1-M23 isoforms. Biophys J 2011, 100:2936-2945.
31. Verkman AS Aquaporins in clinical medicine. Annu Rev Med 2012, 63:303-316.
32. Rash JE, Yasumura T, Hudson CS, Agre P, Nielsen S Direct immunogold labeling of aquaporin-4 in square arrays of astrocyte and ependymocyte plasma membranes in rat brain and spinal cord. Proc Natl Acad Sci USA 1998, 95:11981-11986.
33. Nielsen S, Nagelhus EA, Amiry-Moghaddam M, Bourque C, Agre P, Ottersen OP Specialized membrane domains for water transport in glial cells: high-resolution immunogold cytochemistry of aquaporin-4 in rat brain. J Neurosci 1997, 17:171-180.
34. Li J, Patil RV, Verkman AS Mildly abnormal retinal function in transgenic mice without Muller cell aquaporin-4 water channels. Invest Ophthalmol Vis Sci 2002, 43:573-579.
35. Ma T, Yang B, Gillespie A, Carlson EJ, Epstein CJ, Verkman AS Generation and phenotype of a transgenic knockout mouse lacking the mercurial-insensitive water channel aquaporin-4. J Clin Invest 1997, 100:957-962.
36. Yang B, Verbavatz JM, Song Y, et al. Skeletal muscle function and water permeability in aquaporin-4 deficient mice. Am J Physiol Cell Physiol 2000, 278:C1108-C1115.
37. Li J, Verkman AS Impaired hearing in mice lacking aquaporin-4 water channels. J Biol Chem 2001, 276:31233-31237.
38. Lu DC, Zhang H, Zador Z, Verkman AS Impaired olfaction in mice lacking aquaporin-4 water channels. FASEB J 2008, 22:3216-3223.
39. Manley GT, Fujimura M, Ma T, et al. Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke. Nat Med 2000, 6:159-163.
40. Papadopoulos MC, Manley GT, Krishna S, Verkman AS Aquaporin-4 facilitates reabsorption of excess fluid in vasogenic brain edema. FASEB J 2004, 18:1291-1293.
41. Bloch O, Auguste KI, Manley GT, Verkman AS Accelerated progression of kaolin-induced hydrocephalus in aquaporin-4-deficient mice. J Cereb Blood Flow Metab 2006, 26:1527-1537.
42. Saadoun S, Bell BA, Verkman AS, Papadopoulos MC Greatly improved neurological outcome after spinal cord compression injury in AQP4-deficient mice. Brain 2008, 131:1087-1098.
43. Kimura A, Hsu M, Seldin M, Verkman AS, Scharfman HE, Binder DK Protective role of aquaporin-4 water channels after contusion spinal cord injury. Ann Neurol 2010, 67:794-801.
44. Binder DK, Yao X, Zador Z, Sick TJ, Verkman AS, Manley GT Increased seizure duration and slowed potassium kinetics in mice lacking aquaporin-4 water channels. Glia 2006, 53:631-636.
45. Saadoun S, Papadopoulos MC, Watanabe H, Yan D, Manley GT, Verkman AS Involvement of aquaporin-4 in astroglial cell migration and glial scar formation. J Cell Sci 2005, 118:5691-5698.
46. Li L, Zhang H, Varrin-Doyer M, Zamvil SS, Verkman AS Proinflammatory role of aquaporin-4 in autoimmune neuroinflammation. FASEB J 2011, 25:1556-1566.
47. Nicchia GP, Mastrototaro M, Rossi A, et al. Aquaporin-4 orthogonal arrays of particles are the target for neuromyelitis optica autoantibodies. Glia 2009, 57:1363-1373.
48. Hinson SR, Romero MF, Popescu BF, et al. Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes. Proc Natl Acad Sci USA 2011, 109:1245-1250.
49. Bennett JL, Lam C, Kalluri SR, et al. Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica. Ann Neurol 2009, 66:617-629.
50. Pisani F, Mastrototaro M, Rossi A, et al. Identification of two major conformational aquaporin-4 epitopes for neuromyelitis optica autoantibody binding. J Biol Chem 2011, 286:9216-9224.
51. Yu X, Green M, Gilden D, Lam C, Bautista K, Bennett JL Identification of peptide targets in neuromyelitis optica. J Neuroimmunol 2011, 236:65-71.
52. Waters P, Vincent A Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: current status of the assays. Int MS J 2008, 15:99-105.
53. Rossi A, Ratelade J, Papadopoulos MC, Benett JL, Verkman AS. Consequences of NMO-IgG binding to aquaporin-4 in neuromyelitis optica. PNAS (in press).
54. Hinson SR, Pittock SJ, Lucchinetti CF, et al. Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica. Neurology 2007, 69:2221-2231.
55. Ratelade J, Bennett JL, Verkman AS Evidence against cellular internalization in vivo of NMO-IgG, aquaporin-4, and excitatory amino acid transporter 2 in neuromyelitis optica. J Biol Chem 2011, 286:45156-45164.
56. Saadoun S, Waters P, Bell BA, Vincent A, Verkman AS, Papadopoulos MC Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice. Brain 2010, 133:349-361.
57. Tradtrantip L, Zhang H, Saadoun S, et al. Anti-aquaporin-4 monoclonal antibody blocker therapy for neuromyelitis optica. Ann Neurol 2012, 71:314-322.
58. Bennett JL, Lam C, Kalluri SR, et al. Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica. Ann Neurol 2009, 66:617-629.
59. Ratelade J, Zhang H, Saadoun S, Bennett JL, Papadopoulos MC, Verkman AS Neuromyelitis optica IgG and natural killer cells produce NMO lesions in mice without myelin loss. Acta Neuropathol 2012, published online April 22. 10.1007/s00401-012-0986-4.
60. Lucchinetti CF, Mandler RN, McGavern D, et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 2002, 125:1450-1461.
61. Roemer SF, Parisi JE, Lennon VA, et al. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 2007, 130:1194-1205.
62. Misu T, Fujihara K, Kakita A, et al. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain 2007, 130:1224-1234.
63. Lucchinetti CF, Mandler RN, McGavern D, et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 2002, 125:1450-1461.
64. Jarius S, Franciotta D, Bergamaschi R, Wildemann B, Wandinger KP Immunoglobulin M antibodies to aquaporin-4 in neuromyelitis optica and related disorders. Clin Chem Lab Med 2010, 48:659-663.
65. Jarius S, Wildemann B AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance. Nat Rev Neurol 2010, 6:383-392.
66. Saadoun S, Waters P, MacDonald C, et al. Neutrophil protease inhibition reduces NMO-IgG-induced damage in mouse brain. Ann Neurol 2012, 71:323-333.
67. Herges K, de Jong BA, Kolkowitz I, et al. Protective effect of an elastase inhibitor in a neuromyelitis optica-like disease driven by a peptide of myelin oligodendroglial glycoprotein. Mult Scler 2012, 18:398-408.
68. Jacob A, Saadoun S, Kitley J, et al. Detrimental role of granulocyte-colony stimulating factor in neuromyelitis optica: clinical case and histological evidence. Mult Scler 2012, published online April 11. 10.1177/1352458512443994.
69. Kita H Eosinophils: multifaceted biological properties and roles in health and disease. Immunol Rev 2011, 242:161-177.
70. Bradl M, Misu T, Takahashi T, et al. Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo. Ann Neurol 2009, 66:630-643.
71. Kinoshita M, Nakatsuji Y, Kimura T, et al. Neuromyelitis optica: passive transfer to rats by human immunoglobulin. Biochem Biophys Res Commun 2009, 386:623-627.
72. Zhang H, Bennett JL, Verkman AS Ex vivo spinal cord slice model of neuromyelitis optica reveals novel immunopathogenic mechanisms. Ann Neurol 2011, 70:943-954.
73. Jarius S, Franciotta D, Paul F, et al. Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance. J Neuroinflammation 2010, 7:52.
74. Misu T, Takano R, Fujihara K, Takahashi T, Sato S, Itoyama Y Marked increase in cerebrospinal fluid glial fibrillar acidic protein in neuromyelitis optica: an astrocytic damage marker. J Neurol Neurosurg Psychiatry 2009, 80:575-577.
75. Jarius S, Paul F, Franciotta D, et al. Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures. J Neurol Sci 2011, 306:82-90.
76. Matsushita T, Tateishi T, Yonekawa T, Isobe N, Kira JI. Increased CSF IL-17A, IL-6, CXCL8 and CXCL10 in patients with neuromyelitis optica at relapse and their clinical relevance. 5th Joint triennial congress of the European and Americas Committees for Treatment and Research in Multiple Sclerosis; Amsterdam, Netherlands; Oct 19-22 2011. 56.
77. Hendriks JJ, Teunissen CE, de Vries HE, Dijkstra CD Macrophages and neurodegeneration. Brain Res Rev 2005, 48:185-195.
78. Kleiter I, Hellwig K, Berthele A, et al. Severe exacerbations of neuromyelitis optica during natalizumab therapy. ECTRIMS 2011 meeting; Oct 19-22 2011. 660.
79. Barnett M, Prineas J, Buckland M, Parratt J, Pollard J Massive astrocyte destruction in neuromyelitis optica despite natalizumab therapy. Mult Scler 2012, 18:108-112.
80. Kirveskari J, Bono P, Granfors K, Leirisalo-Repo M, Jalkanen S, Salmi M Expression of alpha4-integrins on human neutrophils. J Leukoc Biol 2000, 68:243-250.
81. Marignier R, Nicolle A, Watrin C, et al. Oligodendrocytes are damaged by neuromyelitis optica immunoglobulin G via astrocyte injury. Brain 2010, 133:2578-2591.
82. Jarius S, Ruprecht K, Wildemann B, et al. Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients. J Neuroinflammation 2012, 9:14.
83. McKeon A, Pittock SJ, Lennon VA CSF complements serum for evaluating paraneoplastic antibodies and NMO-IgG. Neurology 2011, 76:1108-1110.
84. Waters PJ, McKeon A, Leite MI, et al. Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays. Neurology 2012, 78:665-671.
85. Mader S, Gredler V, Schanda K, et al. Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders. J Neuroinflammation 2011, 8:184.
86. Nishiyama S, Ito T, Misu T, et al. A case of NMO seropositive for aquaporin-4 antibody more than 10 years before onset. Neurology 2009, 72:1960-1961.
87. Apiwattanakul M, Popescu BF, Matiello M, et al. Intractable vomiting as the initial presentation of neuromyelitis optica. Ann Neurol 2010, 68:757-761.
88. Iorio R, Lucchinetti CF, Lennon VA, et al. Syndrome of inappropriate antidiuresis may herald or accompany neuromyelitis optica. Neurology 2011, 77:1644-1646.
89. Hofman P, Hoyng P, vanderWerf F, Vrensen GF, Schlingemann RO Lack of blood-brain barrier properties in microvessels of the prelaminar optic nerve head. Invest Ophthalmol Vis Sci 2001, 42:895-901.
90. Bartanusz V, Jezova D, Alajajian B, Digicaylioglu M The blood-spinal cord barrier: morphology and clinical implications. Ann Neurol 2011, 70:194-206.
91. Koga M, Takahashi T, Kawai M, Fujihara K, Kanda T A serological analysis of viral and bacterial infections associated with neuromyelitis optica. J Neurol Sci 2011, 300:19-22.
92. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999, 53:1107-1114.
93. Roopenian DC, Akilesh S FcRn: the neonatal Fc receptor comes of age. Nat Rev Immunol 2007, 7:715-725.
94. Oshio K, Binder DK, Yang B, Schecter S, Verkman AS, Manley GT Expression of aquaporin water channels in mouse spinal cord. Neuroscience 2004, 127:685-693.
95. Chihara N, Aranami T, Sato W, et al. Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica. Proc Natl Acad Sci USA 2011, 108:3701-3706.
96. Ratelade J, Bennett JL, Verkman AS Intravenous neuromyelitis optica autoantibody in mice targets aquaporin-4 in peripheral organs and area postrema. PLoS One 2011, 6:e27412.
97. Suzuki N, Takahashi T, Aoki M, et al. Neuromyelitis optica preceded by hyperCKemia episode. Neurology 2010, 74:1543-1545.
98. Ma T, Yang B, Verkman AS Gene structure, cDNA cloning, and expression of a mouse mercurial-insensitive water channel. Genomics 1996, 33:382-388.
99. Zipfel PF, Skerka C Complement regulators and inhibitory proteins. Nat Rev Immunol 2009, 9:729-740.
100. Faulkner JR, Herrmann JE, Woo MJ, Tansey KE, Doan NB, Sofroniew MV Reactive astrocytes protect tissue and preserve function after spinal cord injury. J Neurosci 2004, 24:2143-2155.
101. Wasseff SK, Scherer SS Cx32 and Cx47 mediate oligodendrocyte:astrocyte and oligodendrocyte:oligodendrocyte gap junction coupling. Neurobiol Dis 2011, 42:506-513.
102. Hinson SR, Roemer SF, Lucchinetti CF, et al. Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2. J Exp Med 2008, 205:2473-2481.
103. Auguste KI, Jin S, Uchida K, et al. Greatly impaired migration of implanted aquaporin-4-deficient astroglial cells in mouse brain toward a site of injury. FASEB J 2007, 21:108-116.
104. Takahashi T, Fujihara K, Nakashima I, et al. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain 2007, 130:1235-1243.
105. Saadoun S, Waters P, Macdonald C, et al. T cell deficiency does not reduce lesions in mice produced by intracerebral injection of NMO-IgG and complement. J Neuroimmunol 2011, 235:27-32.
106. Min JH, Kim BJ, Lee KH Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder. Mult Scler 2012, 18:113-115.
107. Nelson PA, Khodadoust M, Prodhomme T, et al. Immunodominant T cell determinants of aquaporin-4, the autoantigen associated with neuromyelitis optica. PLoS One 2010, 5:e15050.
108. Palace J, Leite MI, Nairne A, Vincent A. Interferon beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers. Arch Neurol; 67: 1016-17.
109. Tanaka M, Tanaka K, Komori M Interferon-beta(1b) treatment in neuromyelitis optica. Eur Neurol 2009, 62:167-170.
110. Krumbholz M, Faber H, Steinmeyer F, et al. Interferon-beta increases BAFF levels in multiple sclerosis: implications for B cell autoimmunity. Brain 2008, 131:1455-1463.
111. Tradtrantip L, Zhang H, Anderson MO, et al. Small-molecule inhibitors of NMO-IgG binding to aquaporin-4 reduce astrocyte cytotoxicity in neuromyelitis optica. FASEB J 2012, published online Feb 8. 10.1096/fj.11-201608.
112. Allen NJ, Barres BA Neuroscience: glia-more than just brain glue. Nature 2009, 457:675-677.
113. von Vietinghoff S, Ley K Homeostatic regulation of blood neutrophil counts. J Immunol 2008, 181:5183-5188.